Are biphosphonates efficient in the adjuvant treatment of lung cancer?

F. Vlastos, N. Cassou, C. Clement-Duchene, C. Carnin, N. Martinet, Y. Martinet (Athens, Greece; Vandoeuvre les Nancy, Nancy, France)

Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Session: Treatment and complications of treatment of lung cancer and malignant pleural effusions
Session type: Electronic Poster Session
Number: 4326
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Vlastos, N. Cassou, C. Clement-Duchene, C. Carnin, N. Martinet, Y. Martinet (Athens, Greece; Vandoeuvre les Nancy, Nancy, France). Are biphosphonates efficient in the adjuvant treatment of lung cancer?. Eur Respir J 2006; 28: Suppl. 50, 4326

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011


Adjuvant therapy in NSCLC
Source: Annual Congress 2007 - Clinical year in review
Year: 2007


Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Cryotherapy as an adjuvant to radiotherapy in lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 76s
Year: 2005

Effectiveness of chemotherapy for advanced lung cancer in the elderly
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?
Source: Eur Respir J 2003; 22: 535-541
Year: 2003



Neoadjuvant and adjuvant treatment for operable nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 244–259
Year: 2009

Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019


Targeted therapy for lung cancer
Source: Eur Respir J 2015; 46: 1239-1241
Year: 2015


Current neoadjuvant/adjuvant treatment for advanced stage lung cancer
Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer
Year: 2014

Mianserin therapy in advanced lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Is there any place for perioperative radiation therapy?
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Early stage nonsmall-cell lung cancer: therapeutic options (surgery, adjuvant and neoadjuvant therapy)
Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course
Year: 2011


Optimal integration of chemo- and radiotherapy in small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006


Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001

Dexamethasone improves antiemetic control in lung cancer patients treated with chemotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 434s
Year: 2007

Adjuvant and neoadjuvant therapy in nonsmall cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Clinical year in review
Year: 2006


Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 752s
Year: 2006